Alantra advises Mobile Vascular Physicians on the sale of a minority stake to Housatonic Partners

Dec 2021

Growth investment

New York – Alantra, a leading global investment bank and asset management firm, is pleased to announce that it has advised Mobile Vascular Physicians (“MVP”) on a strategic growth investment by Housatonic Partners, a growth-oriented private equity firm focused on investing in market-leading services companies. The transaction closed on December 31, 2021, and the transaction terms were not disclosed.

New York-based Mobile Vascular Physicians is a concierge vascular and interventional service (commonly called ‘special procedures’) with a concentration in lower extremity venous and arterial disease. MVP provides clinical consultation, diagnostic work up, and minimally-invasive venous treatments to the patients that they service, ensuring the highest standards in vascular care while maximizing both convenience and patient outcomes.

Housatonic Partners invests in growing, profitable businesses with highly recurring revenue. The strategic growth investment by Housatonic Partners will allow MVP to continue on its growth trajectory and further their expansion plans.

“MVP’s high-quality care offering has afforded the company tremendous growth,” said Rusty Ray, Managing Partner with Alantra. “It was a pleasure working with the team to secure additional capital which will accelerate the growth of the business in key, new markets.  While the timeline for the transaction was exceptionally compressed, we were able to work diligently with the company and buyer to meet expectations.”

Alantra acted as sole financial advisor to MVP on this transaction. The Alantra US Healthcare team advising Mobile Vascular Physicians included Mr. Ray, Darius Kuddo (Analyst), and Michaela Zhang (Analyst).